Resistin regulates the expression of plasminogen activator inhibitor-1 in 3T3-L1 adipocytes.

[1]  K. Kogure,et al.  Resistin affects lipid metabolism during adipocyte maturation of 3T3‐L1 cells , 2013, The FEBS journal.

[2]  M. Uhler,et al.  Protein Kinase A Modulates Transforming Growth Factor-β Signaling through a Direct Interaction with Smad4 Protein* , 2013, The Journal of Biological Chemistry.

[3]  K. Kogure,et al.  Quantitative comparison of adipocytokine gene expression during adipocyte maturation in non-obese and obese rats. , 2011, Biological & pharmaceutical bulletin.

[4]  R. Saif-Ali,et al.  Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects , 2011, Cardiovascular diabetology.

[5]  D. D. de Luis,et al.  Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients. , 2010, Diabetes research and clinical practice.

[6]  A. Chabowski,et al.  Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  O. Franco,et al.  Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese. , 2008, European journal of endocrinology.

[8]  Chao-Yung Wang,et al.  Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  Hui Liao,et al.  Molecular regulation of the PAI‐1 gene by hypoxia: contributions of Egr‐1, HIF‐1 α, and C/EBPα , 2007 .

[10]  M. Maki,et al.  Calpain system regulates the differentiation of adult primitive mesenchymal ST-13 adipocytes. , 2006, Endocrinology.

[11]  H. Towle,et al.  ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.

[12]  M. J. Yoon,et al.  Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator–Activated Receptor α , 2006, Diabetes.

[13]  Duan Ma,et al.  Identification of a peroxisome proliferator responsive element (PPRE)-like cis-element in mouse plasminogen activator inhibitor-1 gene promoter. , 2006, Biochemical and biophysical research communications.

[14]  S. Kahn,et al.  Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans , 2005, Diabetologia.

[15]  Stephen W. Michnick,et al.  PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3 , 2004, Nature Cell Biology.

[16]  O. McGuinness,et al.  Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. , 2004, Diabetes.

[17]  P. Morange,et al.  Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk , 2003, Journal of thrombosis and haemostasis : JTH.

[18]  Mayumi Sato,et al.  Mechanism of adult primitive mesenchymal ST-13 preadipocyte differentiation. , 2003, Endocrinology.

[19]  B. Wadzinski,et al.  Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Rossetti,et al.  Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. , 2003, The Journal of clinical investigation.

[21]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[22]  H. Sul,et al.  A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation* , 2001, The Journal of Biological Chemistry.

[23]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[24]  A. Ahlbom,et al.  Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  B. Spiegelman,et al.  Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity , 1999 .

[26]  L. Weinehall,et al.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. , 1998, Circulation.

[27]  B. Spiegelman,et al.  Posttranscriptional Control of Adipocyte Differentiation through Activation of Phosphoinositide 3-Kinase* , 1998, The Journal of Biological Chemistry.

[28]  A. Scheurink,et al.  Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. , 1998, European journal of endocrinology.

[29]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[30]  H. Mitsui,et al.  Establishment of a clonal cell line that differentiates into adipose cells in vitro , 1980, In Vitro.